https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ADyslipidemia%2F22%2FenTranslations:Dyslipidemia/22/en - Revision history2026-09-13T22:58:24ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Dyslipidemia/22/en&diff=138782&oldid=prevFuzzyBot: Importing a new version from external source2024-04-13T08:52:05Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>=== PCSK9 inhibitors ===<br />
PCSK9 inhibitors are monoclonal antibodies that target an important protein in the degradation of LDL called proprotein convertase substilisin/kexin type 9 ([[PCSK9]]). These agents reduce LDL-C, increase HDL-C, decrease triglycerides, and decrease lipoprotein(a). The FOURNIER and ODYSSEY trials showed that these agents also reduced the risk of cardiovascular events.</div>FuzzyBot